Follow
Hana M. Zegallai, PhD
Hana M. Zegallai, PhD
Department of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, Canada DREAM, Children
Verified email at myumanitoba.ca
Title
Cited by
Cited by
Year
Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets
HM Zegallai, GM Hatch
Molecular and cellular biochemistry 476, 1605-1629, 2021
422021
Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts
EM Mejia, H Zegallai, ED Bouchard, V Banerji, A Ravandi, GM Hatch
Journal of Biological Chemistry 293 (20), 7564-7577, 2018
332018
Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice
HM Zegallai, E Abu‐El‐Rub, LK Cole, J Field, EM Mejia, JW Gordon, ...
The FASEB Journal 35 (12), e22023, 2021
122021
Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes
HM Zegallai, E Abu‐El‐Rub, F Olayinka‐Adefemi, LK Cole, GC Sparagna, ...
The FASEB Journal 36 (8), e22443, 2022
52022
Mesenchymal stem cells and COVID-19: What they do and what they can do
E Abu-El-Rub, RR Khasawneh, F Almahasneh, Z Altaany, N Bataineh, ...
World journal of stem cells 13 (9), 1318, 2021
52021
Addressing the impact of high glucose microenvironment on the immunosuppressive characteristics of human mesenchymal stem cells
RR Khasawneh, E Abu‐El‐Rub, FA Almahasneh, A Alzu'bi, HM Zegallai, ...
IUBMB life 76 (5), 286-295, 2024
42024
Tafazzin regulates the function of lipopolysaccharide activated B lymphocytes in mice
HM Zegallai, E Abu-El-Rub, LK Cole, J Field, EM Mejia, JW Gordon, ...
bioRxiv, 2021.05. 17.444507, 2021
22021
The Molecular and Functional Changes of Neural Stem Cells in Alzheimer’s Disease: Can They be Reinvigorated to Conduct Neurogenesis
E Abu-El-Rub, RR Khasawneh, FA Almahasneh, BM Aloud, HM Zegallai
Current Stem Cell Research & Therapy 18 (5), 580-594, 2023
12023
Tafazzin deficiency attenuates anti-cluster of differentiation 40 and interleukin-4 activation of mouse B lymphocytes
HM Zegallai, E Abu-El-Rub, EM Mejia, GC Sparagna, LK Cole, ...
Cell and Tissue Research 390 (3), 429-439, 2022
12022
Impaired surface marker expression in stimulated Epstein-Barr virus transformed lymphoblasts from Barth Syndrome patients
HM Zegallai, GM Hatch
Scientific Reports 12 (1), 6195, 2022
12022
Mesenchymal stem cells derived secretome as an innovative cell-free therapeutic approach
E Abu-El-Rub, RR Khasawneh, FA Almahasneh, HM Zegallai
Biocell 46 (4), 907, 2022
12022
Reduced protein kinase C delta association with a higher molecular weight complex in mitochondria of Barth Syndrome lymphoblasts
EM Mejia, HM Zegallai, GC Sparagna, GM Hatch
bioRxiv, 2021.07. 21.453087, 2021
12021
Reduction in mRNA Expression of the Neutrophil Chemoattract Factor CXCL1 in Pseudomonas aeruginosa Treated Barth Syndrome B Lymphoblasts
HM Zegallai, K Duan, GM Hatch
Biology 12 (5), 730, 2023
2023
Tafazzin knockdown in murine mesenchymal stem cells enhances the tafazzin knockdown mediated elevation in interleukin-10 secretion from murine B lymphocytes
HM Zegallai, E Abu-El-Rub, GM Hatch
bioRxiv, 2023.03. 01.530640, 2023
2023
The impact of Tafazzin deficiency on the functional and immunological characteristics of B lymphocytes
H Zegallai
2022
Tafazzin deficiency in mouse mesenchymal stem cells potentiates their immunosuppression and impairs activated B lymphocyte immune function
HM Zegallai, E Abu-El-Rub, F Olayinka-Adefemi, LK Cole, GC Sparagna, ...
bioRxiv, 2021.09. 07.459330, 2021
2021
WJSC
E Abu-El-Rub, RR Khasawneh, F Almahasneh, Z Altaany, N Bataineh, ...
2021
WJSC
AN Sant'Ana, AB Araújo, FDC Gonçalves, AH Paz, A Goutas, V Trachana, ...
The system can't perform the operation now. Try again later.
Articles 1–18